FOXP3 and myeloid sarcoma: Treg cells from MS patients have been shown to express lower levels of FoxP3 (187), and a more detailed study later showed that in patients there is prevalent expression of the FoxP3 isoform lacking exon2, making Treg cells less efficient in inhibiting the development of proinflammatory cells (28).